Table 2. Effects of 8-prenylgenistein on trabecular bone parameters measured by micro-CT at the proximal metaphysis of tibia (A) and the distal metaphysis of femur (B) in ovariectomized mice.
A | |||||
Parameters\Group | Sham | OVX | Gen | 8PG-L | 8PG-H |
BMD/TV (mg HA/ccm) | 105 ± 7 | 59 ± 3## | 67 ± 9 | 74 ± 6 | 85 ± 6* |
Conn.D (1/mm3) | 360 ± 55 | 136 ± 31# | 211 ± 32 | 197 ± 15 | 202 ± 18 |
BV/TV (%) | 87.9 ± 5.9 | 50.7 ± 5.7## | 67.7 ± 12.8 | 71.3 ± 11.3 | 77.0 ± 13.5 |
DA | 1.35 ± 0.04 | 1.81 ± 0.03# | 1.60 ± 0.08 | 1.34 ± 0.05* | 1.34 ± 0.03* |
Tb.N (1/mm) | 2.7 ± 0.1 | 1.6 ± 0.1### | 1.9 ± 0.2 | 1.9 ± 0.2 | 1.9 ± 0.2 |
Tb.Sp μm) | 337 ± 17 | 591 ± 48## | 498 ± 72 | 509 ± 55 | 439 ± 43* |
Tb.Th (μm) | 33.3 ± 1.0 | 30.8 ± 2.2 | 33.8 ± 4.9 | 36.7 ± 2.3 | 39.8 ± 1.4** |
B | |||||
Parameters\Group | Sham | OVX | Gen | 8PG-L | 8PG-H |
BMD/TV (mg HA/ccm) | 149 ± 15 | 97 ± 7# | 137 ± 7* | 141 ± 13* | 151 ± 8** |
Conn.D (1/mm3) | 266 ± 40 | 135 ± 26# | 210 ± 40 | 179 ± 19 | 192 ± 22 |
BV/TV (%) | 16.6 ± 2.1 | 10.1 ± 0.6# | 16.8 ± 0.9** | 15.9 ± 1.9* | 19.7 ± 1.2** |
DA | 1.27 ± 0.02 | 1.34 ± 0.10 | 1.34 ± 0.05 | 1.25 ± 0.03 | 1.30 ± 0.07 |
Tb.N (1/mm) | 3.5 ± 0.2 | 2.3 ± 0.1## | 3.0 ± 0.2* | 3.1 ± 0.2* | 3.2 ± 0.2* |
Tb.Sp (μm) | 243 ± 17 | 385 ± 13### | 273 ± 17** | 295 ± 27* | 257 ± 24** |
Tb.Th (μm) | 52.3 ± 2.2 | 43.5 ± 2.9# | 54.9 ± 3.8 | 59.6 ± 3.7* | 62.4 ± 0.8** |
Values were expressed as means ± SEM, n = 8 in each group. #P < 0.05, ##P < 0.01, ###P < 0.001, vs. Sham; *P < 0.05, **P < 0.01, vs. OVX. BMD/TV, bone mineral density over total volume; Conn.D, connectivity density; BV/TV, bone volume over total volume; DA, degree of anisotropy; Tb.N, trabecular bone number; Tb.Sp, trabecular bone separation; Tb.Th, trabecular bone thickness.